Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Braulio Bonilla
Graduate Student Researcher
Email
brauliobonilla@pitt.edu

Education
MS, Molecular and Cell Biology, Universidad de la Republica, Uruguay, 2008
BS, Biological Sciences, Universidad de la Republica, Uruguay, 2008
 


Funding Source
Fulbright Scholarship


Awards Received
Fulbright Scholarship


Faculty Mentor
Kara A. Bernstein, PhD
G.5C Hillman Cancer Center 5117 Centre Avenue
Photo of Braulio  Bonilla



Research

I am interested in understanding how failure of the DNA repair mechanisms lead to genomic instability; specifically I try to elucidate the function of the Shu complex in in preventing mutagenesis.
 


Publications/Abstracts
Rojas JJ, Sampath P, Bonilla B, Ashley A, Hou W, Byrd D, Thorne SH.Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies. Cell Rep. 2016 Apr 12;15(2):264-73. PMID:  27050526 PMCID: PMC4830920

 
STUDENT NEWS


UPCOMING EVENTS
11/27/2017 8:30 AM Molecular Pharmacology Journal Club
Lloyd Harvey


11/30/2017 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jeffrey L. Brodsky, Ph.D.


12/4/2017 8:30 AM Molecular Pharmacology Journal Club
Andrew Lamade


Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Molecular Pharmacology Graduate Program Ranked #2 in Faculty Scholarly Productivity Index


Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty consecutive years




Back to Top